Skip to Content

3137 WPI (Nizatidine 150 mg)

Pill imprint 3137 WPI has been identified as Nizatidine 150 mg.

Nizatidine is used in the treatment of gerd; indigestion; erosive esophagitis; duodenal ulcer; duodenal ulcer prophylaxis (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Nizatidine 150 mg 3137 WPI
Nizatidine 150 mg 3137 WPI
Discount Card Promo
Nizatidine
Imprint:
3137 WPI
Strength:
150 mg
Color:
White
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-3137
Inactive Ingredients:
silicon dioxide colloidal
corn starch
croscarmellose sodium
magnesium stearate
pregelatinized corn starch
ammonia
ferric oxide black
gelatin
potassium hydroxide
propylene glycol
shellac
silicon dioxide
sodium lauryl sulfate
titanium dioxide
D&C Yellow No. 10
FD&C Yellow No. 6
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
21695-0375 Rebel Distributors Corp (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide